Authors: Lang, S Zeidler, R Pauli, C Andratschke, M Wollenberg, B

Citation: S. Lang et al., Targeting head and neck cancer by IL-2-mediated gene therapy: From bench to bedside - A review., LARY RH OTO, 80(4), 2001, pp. 191-195

Authors: Andratschke, M Helmberger, R Mees, K

Citation: M. Andratschke et al., The differential diagnosis of the parapharyngeal mass., LARY RH OTO, 79(3), 2000, pp. 174-179

Authors: Wollenberg, B",Kastenbauer,"Mundl, H Schaumberg, J Mayer, A Andratschke, M Lang, S Pauli, C Zeidler, R Ihrler, S",Lohrs,"Naujoks, K

Citation: H. Wollenberg, B",kastenbauer,"mundl et al., Gene therapy - Phase I trial for primary untreated head and neck squamous cell cancer (HNSCC) UICC stage II-IV with a single intratumoral injection of hIL-2 plasmids formulated in DOTMA/Chol, HUM GENE TH, 10(1), 1999, pp. 141-147